Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: Comparison with other CXCR3 ligands

Laboratory Investigation

Volumn 84, Issue 11, 2004, Pages 1418-1429

  McColl, Shaun R ^a   Mahalingam, Surendran ^a,d   Staykova, Maria ^b   Tylaska, Laurie A ^c   Fisher, Katherine E ^c   Strick, Christine A ^c   Gladue, Ronald P ^c   Neote, Kuldeep S ^c   Willenborg, David O ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b CANBERRA HOSPITAL   (Australia)

^c PFIZER INC   (United States)

^d UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Autoimmunity; Chemokine; CXCL11; EAE; Inflammation

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; INTERLEUKIN 1BETA; MYELIN BASIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL MIGRATION; CELL TRANSPORT; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CHEMOKINE GENE; CHEMOTAXIS; COMPARATIVE STUDY; CONTROLLED STUDY; CXCL10 GENE; CXCL11 GENE; CXCL9 GENE; CXCR3 GENE; EXPRESSED SEQUENCE TAG; FEMALE; GENE; GENE EXPRESSION; I TAC CXCL11 GENE; IMMUNITY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; IP 10 CXCL10 GENE; LYMPH NODE; LYMPH NODE CELL; LYMPHOCYTE MIGRATION; MIG CXCL9 GENE; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PASSIVE TRANSPORT; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCYA11 GENE; SPINAL CORD; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CHEMOKINES, CC; CHEMOKINES, CXC; CHEMOTAXIS; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; LIGANDS; LYMPH NODES; MOLECULAR SEQUENCE DATA; RATS; RATS, INBRED LEW; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTES;

EID: 8344227629     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3700155     Document Type: Article

References (44)

1. Janeway CA, Travers P. Immunobiology. The immune system in health and disease. Churchill Livingstone: London, 1997.
2. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-66.
3. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Ann Rev Immunol 1997;15:675-705.
4. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998;392:565-568.
5. Gale LM, McColl SR. Chemokines: extracellular messengers for all occasions? Bioessays 1999;21:17-28.
6. Oppenheim JJ, Zachariae CO, Mukaida N, et al. Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Ann Rev Immunol 1991;9: 617-648.
7. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 1994;6: 865-873.
8. + T cells. Science 1995;270:1811-1815.
9. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 [see comments]. Nature 1996;381:667-673.
10. Feng Y, Broder CC, Kennedy PE, et al. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272:872-877.
11. Zimmerman PA, Buckler White A, Alkhatib G, et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 1997;3:23-36.
12. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000;12: 121-127.
13. Cole KE, Strick CA, Paradis TJ, et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 1998;187:2009-2021.
14. Luster AD, Ravetch JV. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 1987;166:1084-1097.
15. Farber JM. A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. Proc Natl Acad Sci USA 1990;87:5238-5242.
16. Loetscher M, Gerber B, Loetscher P, et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996;184:963-969.
17. Bonecchi R, Bianchi G, Bordignon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-134.
18. Loetscher M, Gerber B, Loetscher P, et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996;184:963-969.
19. Sallusto F, Lenig D, Mackay CR, et al. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875-883.
20. Ebert LM, Caon AC, Clark-Lewis I, et al. Coregulation of chemokine receptors and CD4 during allogeneic activation of T lymphocytes. J Immunol 2001;166: 4870-4878.
21. Arimilli S, Ferlin W, Solvason N, et al. Chemokines in autoimmune diseases. Immunol Rev 2000;177: 43-51.
22. Balashov KE, Rottman JB, Weiner HL, et al. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 1999;96:6873-6878.
23. Rottman JB, Smith TL, Ganley KG, et al. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris. Lab Invest 2001;81:335-347.
24. Patel DD, Zachariah JP, Whichard LP. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Immunol 2001;98:39-45.
25. Katschke Jr KJ, Rottman JB, Ruth JH, et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 2001;44:1022-1032.
26. Sauty A, Dziejman M, Taha RA, et al. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 1999;162:3549-3558.
27. Altschul SF, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol 1990;215: 403-410.
28. Nelson RT, Boyd J, Gladue RP, et al. Genomic characterization of the CC chemokine macrophage inflammatory protien-3α (MIP-3α), showing gene structure, splice variants and chromosome localization. Genomics 2001;73:28-37.
29. Tessier PA, Naccache PH, Diener KR, et al. Induction of acute inflammation in vivo by staphylococcal superantigens. II. Critical role for chemokines, ICAM-1, and TNF-alpha. J Immunol 1998;161: 1204-1211.
30. Tessier PA, Naccache PH, Clark-Lewis I, et al. Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J Immunol 1997;159: 3595-3602.
31. Ben-Nun A, Wekerle H, Cohen IR. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating experimental allergic encephalomyelitis. Eur J Immunol 1981;25:1-6.
32. Widney DP, Xia YR, Lusis AJ, et al. The murine chemokine CXCL11 (IFN-inducible T cell alpha chemoattractant) is an IFN-gamma- and lipopolysaccharide-inducible glucocorticoid-attenuated response gene expressed in lung and other tissues during endotoxemia. J Immunol 2000;164:6322-6331.
33. Narumi S, Kaburaki T, Yoneyama H, et al. Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 2002;32:1784-1791.
34. Karpus WJ, Ransohoff RM. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J Immunol 1998;161:2667-2671.
35. Fife BT, Kennedy KJ, Paniagua MC, et al. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 2001;166: 7617-7624.
36. Baron JL, Madri JA, Ruddle NH, et al. Surface expression of alpha 4 integrin by CD4T cells is required for their entry into brain parenchyma. J Exp Med 1993;177:57-68.
37. Kuchroo VK, Martin CA, Greer JM, et al. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 1993;151:4371-4382.
38. Willenborg DO, Parish CR, Cowden WB. Phosphosugars are potent inhibitors of central nervous system inflammation. Faseb J 1989;3:1968-1971.
39. Yong VW, Chabot S, Stuve O, et al. Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology 1998;51:682-689.
40. Karpus WJ, Kennedy KJ, Fife BT, et al. Chemokine regulation of immune-mediated demyelinating disease. Ilar J 1999;40:183-189.
41. Mach F, Sauty A, Iarossi AS, et al. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 1999;104:1041-1050.
42. Hua LL, Lee SC. Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microglia. Glia 2000;30: 74-81.
43. Ren LQ, Gourmala N, Boddeke HW, et al. Lipopolysaccharide-induced expression of IP-10 mRNA in rat brain and in cultured rat astrocytes and microglia. Brain Res Mol Brain Res 1998;59: 256-263.
44. Cox MA, Jenh CH, Gonsiorek W, et al. Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states. Mol Pharmacol 2001;59: 707-715.